14-day Premium Trial Subscription Try For FreeTry Free
$0.590
+0.0074 (+1.27%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.531 $1.35 Friday, 3rd May 2024 VBIV stock ended at $0.590. This is 1.27% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.02% from a day low at $0.570 to a day high of $0.610.
90 days $0.530 $1.35
52 weeks $0.450 $3.47

Historical VBI Vaccines Inc. prices

Date Open High Low Close Volume
Dec 08, 2023 $0.705 $0.724 $0.690 $0.710 70 323
Dec 07, 2023 $0.688 $0.728 $0.680 $0.694 81 110
Dec 06, 2023 $0.647 $0.679 $0.630 $0.679 53 741
Dec 05, 2023 $0.640 $0.650 $0.620 $0.624 34 712
Dec 04, 2023 $0.640 $0.646 $0.615 $0.615 96 818
Dec 01, 2023 $0.620 $0.630 $0.600 $0.614 45 915
Nov 30, 2023 $0.610 $0.625 $0.600 $0.615 53 191
Nov 29, 2023 $0.610 $0.624 $0.600 $0.610 64 520
Nov 28, 2023 $0.591 $0.615 $0.585 $0.610 69 681
Nov 27, 2023 $0.630 $0.632 $0.573 $0.591 86 478
Nov 24, 2023 $0.580 $0.649 $0.520 $0.600 245 100
Nov 22, 2023 $0.740 $0.740 $0.545 $0.550 637 536
Nov 21, 2023 $0.690 $0.760 $0.655 $0.700 210 735
Nov 20, 2023 $0.600 $0.693 $0.550 $0.690 234 926
Nov 17, 2023 $0.583 $0.615 $0.583 $0.615 43 711
Nov 16, 2023 $0.616 $0.616 $0.558 $0.593 98 389
Nov 15, 2023 $0.656 $0.666 $0.622 $0.622 81 323
Nov 14, 2023 $0.645 $0.669 $0.640 $0.650 146 610
Nov 13, 2023 $0.600 $0.699 $0.600 $0.659 613 361
Nov 10, 2023 $0.615 $0.620 $0.591 $0.600 149 351
Nov 09, 2023 $0.630 $0.630 $0.600 $0.600 41 673
Nov 08, 2023 $0.636 $0.639 $0.604 $0.616 75 897
Nov 07, 2023 $0.600 $0.634 $0.600 $0.620 90 235
Nov 06, 2023 $0.610 $0.640 $0.600 $0.600 129 669
Nov 03, 2023 $0.600 $0.650 $0.580 $0.621 238 680
Click to get the best stock tips daily for free!

About VBI Vaccines Inc.

VBI Vaccines. VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP ... VBIV Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT